top of page

Telehealth consultations with home lab kits: the workflow from order to results review

Nov 7
5 min read
Illustration of a telehealth home lab kit workflow: laptop video consult, at-home collection kit, return mailer, lab centrifuge and results tablet in navy and pink

A telehealth consultation with home lab kits follows a loop: a clinician consult and order, a requisition sent to the lab, kit fulfillment, patient self-collection and registration, return shipping, lab accessioning and testing, results routed to the clinician, and a follow-up visit to review results. Each hand-off needs one owner and one status update.


Our earlier post covered what telehealth platforms should ask before adding lab testing. This one is the operational runbook: what happens at each step, who owns it, and where programs usually lose time. It's educational only, not medical or legal advice.



Step 1: Intake and the first consult


Everything starts with a clinical decision. During a synchronous video visit or an asynchronous questionnaire review, a licensed clinician decides whether testing is appropriate and which panel fits.


A few details at this stage prevent problems later:


  • Confirm the patient's location. Licensure follows the patient. Telehealth.HHS.gov advises providers to verify patient location and obtain consent before an appointment.

  • Capture a clean shipping address and a phone number that receives texts, since kit tracking depends on both.

  • Set expectations. Tell the patient what the kit contains, roughly how long the process takes, and that a results review is part of the plan.



Step 2: The order and the requisition


Once the clinician decides to test, the order becomes a requisition. Under CLIA, a lab may only test on the written or electronic request of an authorized person, and the requisition must carry specific details, including patient identifiers, the tests ordered, the ordering provider and a contact for urgent results (42 CFR 493.1241).


On most platforms, this step is automated. The visit note triggers an order through a portal, an EMR interface or an API. Whichever route you use, the requisition should be complete before a kit ships.


The order ID created here should follow the patient through every later step.



Step 3: Kit fulfillment and outbound shipping


Next, a kit has to leave a shelf. Depending on the program, kits ship from the lab, from a fulfillment partner or from the platform's own warehouse. Branded programs often use white-label test kits so the box, inserts and instructions match the platform's look.


Plan for:


  • Kit contents matched to the ordered panel, since different tests need different collection devices

  • Collection device expiration dates and stock rotation

  • Outbound tracking that your support team and the patient can both see

  • A shipping cutoff time, so orders placed late in the day don't sit an extra night



Step 4: Patient self-collection and kit registration


This is the step your team controls least and the one that most affects sample quality. Common home specimen types include fingerstick blood on a collection card or in a small tube, urine, and self-collected swabs. Each test is validated for specific specimen types, so the kit should only include what the lab has approved for that test.


CLIA requires labs to keep written procedures for patient preparation, specimen collection and labeling, and to give those instructions to clients who send them specimens (42 CFR 493.1242). In practice, that means the patient-facing guide should come from the lab's requirements, not from marketing copy.


Kit registration links the physical kit to the order. Usually, the patient scans a QR code or enters a kit ID. Registration matters because an unregistered sample is hard to match to a patient. Good registration flows:


  1. Ask the patient to confirm name and date of birth

  2. Record the collection date and time

  3. Remind the patient about timing, such as fasting or time-of-day instructions, when the test requires it

  4. Show the return-shipping steps right after registration



Step 5: Return shipping


The patient seals the sample and sends it back with a prepaid label. Packaging rules depend on what's inside. USPS treats specimens sent for routine testing not related to infectious disease, such as cholesterol or kidney function tests, as exempt human specimens that still require triple packaging. Specimens for infectious disease testing generally fall under "Biological Substance, Category B" (UN3373) rules (USPS Publication 52, section 346). Your lab or kit supplier should set this up, but your team should know which applies to each panel.


Two operational habits help most:


  • Tell patients which days to collect. Avoid collections right before weekends or holidays, when packages may sit in transit.

  • Watch the return rate. Kits that ship but never come back are often the biggest leak in a home testing program. Automated reminders after a few days can help.



Step 6: Lab accessioning and testing


When the package arrives, the lab accessions it. The lab logs receipt, matches the sample to the requisition and checks it against acceptance criteria. CLIA requires labs to record the date and time they receive each specimen (42 CFR 493.1242).


Samples can be rejected for reasons like too little blood, a missing label, an expired device or too much time in transit. If a sample is rejected, the report must note it (42 CFR 493.1291). Your platform should turn that note into an action, usually a quick reship and a clear message to the patient, not a dead end.


Turnaround depends on the test. Many routine tests result within 24 to 72 hours after the lab receives the sample.



Step 7: Results routing to the clinician


Results go back to the ordering clinician first. Under CLIA, the lab must send results accurately and on time to their final destination, and must immediately alert the ordering party when a result shows a panic or alert value (42 CFR 493.1291).


For a telehealth platform, that means:


  • Structured results land in the patient's chart, ideally with flags for abnormal values

  • A clinician review queue with a clear service window for normal and abnormal results

  • A staffed contact for urgent calls from the lab, including nights and weekends

  • A process for corrected reports, which labs must issue promptly when they find errors



Step 8: The results review consult


This is the second visit in a consultation with home lab kits, and it's what turns a lab test into care. Depending on the result and your clinical protocol, review can be a short async message, a scheduled video visit or an urgent outreach.


Decide in advance:


  • Whether patients see results before, during or after clinician review

  • Which results trigger a required visit versus a message

  • How the plan is documented, including prescriptions, referrals or lifestyle guidance


Patients also have a right to their completed reports. CLIA lets labs release completed test reports directly to patients who request them (42 CFR 493.1291(l)), so your messaging should assume patients may already have seen the numbers.



Step 9: Retesting and recurring orders


Many telehealth programs, such as hormone therapy, weight management or PrEP monitoring, depend on repeat testing. Build retesting into the workflow rather than relying on patient memory:


  • Schedule the next kit based on the clinical protocol

  • Confirm the patient's state and address before each reorder

  • Require a valid, current order from a clinician for each test cycle

  • Track trends over time so the next review starts with context



A one-page status map


Every order should move through visible statuses: ordered, kit shipped, kit delivered, registered, in transit to lab, received, resulted, reviewed and closed. If a status stalls, someone on your team should know within a day.


Labs like IHDLab, which is CLIA-certified (05D2040304), licensed in California, New York and Maryland, and able to ship at-home kits to all 50 states, can handle the kit, testing and results steps. If you're mapping this workflow now, our lab partner for telehealth platforms page shows how those pieces can fit together.

bottom of page